Developing a Web and Tablet based Tool to Improve Communication and Shared Decision Making between Clinicians and Surrogates in ICUs

开发基于网络和平板电脑的工具,以改善 ICU 中临床医生和代理人之间的沟通和共享决策

基本信息

  • 批准号:
    8881427
  • 负责人:
  • 金额:
    $ 19.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2017-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Three decades of research in the United States indicates that Americans who are dying often spend their final days in pain and receiving treatments they would not choose. One in five deaths among adults occurs in or shortly after discharge from an intensive care unit (ICU), where there are well-documented problems with clinician-family communication and end-of-life care. These deficiencies are associated with poorly informed treatment decisions, lasting psychological distress among patients' surrogates, and high utilization of expensive, burdensome treatments at the end of life. Unfortunately, there are no practical, generalizable interventions proven effective in mitigating these three public health problems. In this application, we propose to address this gap by developing a web and tablet-based tool to enhance communication and shared decision making in ICUs, then conducting a pilot RCT among 100 patients assessing the interventions' impact on key elements of decision making quality. In preparation for this application, we conducted in-depth interviews with surrogates and clinicians to assess the acceptability of a web and tablet-based tool, which revealed broad support for the intervention, as well as valuable design suggestions: the tool should be accessible on-line at multiple time-points, and it should be designed to enhance rather than replace clinician-family communication. In Aim 1, We will engage surrogates, clinicians, and experts in a highly iterative process of user- centered design to develop a tool that is usable, accessible, and poses low cognitive load for surrogates. In Aim 2, we will conduct detailed usability and acceptability evaluations of the prototype tool among surrogates of patients with advanced critical illness and critical care physicians and nurses. In Aim 3, we conduct a pilot RCT, using validated instruments to assess the intervention's impact on key elements of decision quality and the patient-centeredness of care decisions. We will also finalize procedures to collect long-term outcome data on patient, family, and health care utilization outcomes, which will be the main outcome measures of the anticipated multi-center trial that will follow. This project will have high impact if successful because it will yield a rigorously developed intervention and crucial preliminary data needed to conduct a multi-center trial to assess the interventions impact on patient and family outcomes. The tool has the potential to overcome major public health problems that affect the more than 600,000 Americans annually who die in ICUs and their family members. This proposal is innovative because it will produce a novel tool that challenges the existing paradigm of how decision support is provided in ICUs. The work is feasible in our hands because our team of established investigators has a proven record of success conducting trials in ICUs, have successfully used all methods proposed in this application, and have obtained buy-in for participation from the clinical sites.
 美国三十年的研究表明,垂死的美国人经常在痛苦中度过最后的日子,并接受他们不会选择的治疗。五分之一的成年人死亡发生在重症监护室(ICU)出院后不久,在那里,临床医生与家人的沟通和临终关怀存在有据可查的问题。这些缺陷与信息不充分的治疗决定,患者代理人的持久心理困扰以及在生命结束时昂贵,繁重的治疗的高利用率有关。 不幸的是,没有实际的、可推广的干预措施被证明能有效缓解这三个公共卫生问题。在本申请中,我们建议通过开发基于网络和平板电脑的工具来解决这一差距,以加强ICU中的沟通和共享决策,然后在100名患者中进行试点RCT,评估干预措施对决策质量关键要素的影响。在准备这项申请时,我们与代理人和临床医生进行了深入的访谈,以评估基于网络和平板电脑的工具的可接受性,这揭示了对干预的广泛支持,以及有价值的设计建议:该工具应在多个时间点在线访问,它应该被设计为加强而不是取代临床医生与家庭的沟通。 在目标1中,我们将让代理人、临床医生和专家参与以用户为中心的设计的高度迭代过程,以开发一种可用、可访问且对代理人造成低认知负荷的工具。在目标2中,我们将在晚期危重病患者和重症监护医生和护士的代理人中对原型工具进行详细的可用性和可接受性评估。在目标3中,我们进行了一项试点随机对照试验,使用经过验证的工具来评估干预措施对决策质量和以患者为中心的护理决策的关键要素的影响。我们还将完成收集患者、家庭和医疗保健利用结果的长期结果数据的程序,这将是随后预期的多中心试验的主要结果指标。 如果成功,该项目将产生巨大影响,因为它将产生严格开发的干预措施和进行多中心试验所需的关键初步数据,以评估干预措施对患者和家庭结局的影响。该工具有可能克服每年影响60多万美国人死于ICU及其家人的重大公共卫生问题。这项建议是创新的,因为它将产生一个新的工具,挑战现有的模式,决策支持是如何在ICU提供。这项工作在我们手中是可行的,因为我们的研究者团队在ICU中成功进行试验的记录已经得到证实,成功使用了本申请中提出的所有方法,并获得了临床研究中心的参与。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas B White其他文献

Racial Differences in Shared Decision-Making About Critical Illness.
关于重大疾病的共同决策的种族差异。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    39
  • 作者:
    D. Ashana;Whitney Welsh;D. Preiss;Jessica Sperling;HyunBin You;Karissa Tu;Shannon S. Carson;Catherine L Hough;Douglas B White;M. Kerlin;Sharron L. Docherty;Kimberly S Johnson;Christopher E. Cox
  • 通讯作者:
    Christopher E. Cox
Critical Care: A Second Special Issue of the Blue Journal
重症监护:蓝色杂志第二期特刊
Critical Care: A Special Issue of the Blue Journal
重症监护:蓝色杂志特刊

Douglas B White的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas B White', 18)}}的其他基金

Randomized Trial of a Scalable, Interactive Tool to Support Surrogate Decision-makers of Elderly Critically Ill Patients
支持老年危重患者代理决策者的可扩展交互式工具的随机试验
  • 批准号:
    10238779
  • 财政年份:
    2020
  • 资助金额:
    $ 19.24万
  • 项目类别:
Randomized Trial of a Scalable, Interactive Tool to Support Surrogate Decision-makers of Elderly Critically Ill Patients
支持老年危重患者代理决策者的可扩展交互式工具的随机试验
  • 批准号:
    10649739
  • 财政年份:
    2020
  • 资助金额:
    $ 19.24万
  • 项目类别:
Randomized Trial of a Scalable, Interactive Tool to Support Surrogate Decision-makers of Elderly Critically Ill Patients
支持老年危重患者代理决策者的可扩展交互式工具的随机试验
  • 批准号:
    10450052
  • 财政年份:
    2020
  • 资助金额:
    $ 19.24万
  • 项目类别:
Mentored Patient Oriented Research in Improving Surrogate Decision Making for Patients with Advanced Respiratory Failure
指导以患者为导向的研究,以改善晚期呼吸衰竭患者的替代决策
  • 批准号:
    10208950
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Mentored Patient Oriented Research in Improving Surrogate Decision Making for Patients with Advanced Respiratory Failure
指导以患者为导向的研究,以改善晚期呼吸衰竭患者的替代决策
  • 批准号:
    10445305
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Mentored Patient Oriented Research in Improving Surrogate Decision Making for Patients with Advanced Respiratory Failure
指导以患者为导向的研究,以改善晚期呼吸衰竭患者的替代决策
  • 批准号:
    9804716
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Mentored Patient Oriented Research in Improving Surrogate Decision Making for Patients with Advanced Respiratory Failure
指导以患者为导向的研究,以改善晚期呼吸衰竭患者的替代决策
  • 批准号:
    10000984
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Mentored Patient Oriented Research in Improving Surrogate Decision Making for Patients with Advanced Respiratory Failure
指导以患者为导向的研究,以改善晚期呼吸衰竭患者的替代决策
  • 批准号:
    10641976
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Stepped Wedge Trial of an Intervention to Support Proxy Decision Makers in ICUs
支持 ICU 代理决策者的干预措施的阶梯楔形试验
  • 批准号:
    8930192
  • 财政年份:
    2014
  • 资助金额:
    $ 19.24万
  • 项目类别:
Stepped Wedge Trial of an Intervention to Support Proxy Decision Makers in ICUs
支持 ICU 代理决策者的干预措施的阶梯楔形试验
  • 批准号:
    9088130
  • 财政年份:
    2014
  • 资助金额:
    $ 19.24万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了